drug protocol number

SKP-LIV_PID_III_2023

drug sponsor

Celgene Corporation

drug study

Golcadomide,BMS-986369 / CC-99282

drug trial site

King Abdulaziz University Hospital (Jeddah), King Fahad Hospital (Jeddah) ,Al-Aziziyah Maternity and Children's Hospital

drug status

Ongoing

drug phase